VBIO is Valion Bio, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $2.77. Market cap: $2M.
Stock snapshot
| Price | $2.77 |
| Market cap | $2M |
| Sector | Healthcare |
| Exchange | NCM |
| Pays dividend | No |
About VBIO
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.
Related non-dividend companies
Other non-dividend stocks investors research alongside VBIO. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is VBIO's current stock price?
VBIO (Valion Bio, Inc.) is currently trading at $2.77.
Does VBIO pay a dividend?
VBIO (Valion Bio, Inc.) does not currently pay a regular dividend.
Track VBIO in DiviDrip
Add VBIO to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search VBIO and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-09-05. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.